ANF-Rho in the Treatment of Chronic Neutropenia

Clinical trial NCT02533362 · WITHDRAWN

Trial details

NCT number: NCT02533362
Sponsor: Prolong Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neutropenia, Severe Chronic

Start date: 2015-10-01
Primary completion: 2016-10-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.